Shufro Rose & Co. LLC lowered its position in shares of Xylem Inc (NYSE:XYL) by 3.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,773 shares of the industrial products company’s stock after selling 770 shares during the quarter. Shufro Rose & Co. LLC’s holdings in Xylem were worth $1,654,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in the company. ETF Managers Group LLC boosted its holdings in shares of Xylem by 7.6% in the first quarter. ETF Managers Group LLC now owns 1,873 shares of the industrial products company’s stock valued at $148,000 after buying an additional 132 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Xylem by 13.4% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 1,134 shares of the industrial products company’s stock valued at $90,000 after buying an additional 134 shares during the period. Thrivent Financial for Lutherans boosted its holdings in shares of Xylem by 1.8% in the fourth quarter. Thrivent Financial for Lutherans now owns 7,864 shares of the industrial products company’s stock valued at $525,000 after buying an additional 138 shares during the period. Manchester Capital Management LLC boosted its holdings in shares of Xylem by 1.0% in the first quarter. Manchester Capital Management LLC now owns 13,863 shares of the industrial products company’s stock valued at $1,096,000 after buying an additional 140 shares during the period. Finally, Huntington National Bank boosted its holdings in shares of Xylem by 2.2% in the second quarter. Huntington National Bank now owns 6,921 shares of the industrial products company’s stock valued at $579,000 after buying an additional 147 shares during the period. Institutional investors own 85.37% of the company’s stock.
XYL traded down $1.28 during trading hours on Friday, hitting $77.53. 966,069 shares of the company’s stock were exchanged, compared to its average volume of 774,681. Xylem Inc has a 1-year low of $60.65 and a 1-year high of $85.39. The firm has a 50-day moving average price of $81.72. The company has a market capitalization of $14.18 billion, a PE ratio of 26.92, a price-to-earnings-growth ratio of 1.49 and a beta of 1.19. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.02 and a current ratio of 1.47.
Xylem (NYSE:XYL) last posted its quarterly earnings results on Thursday, August 1st. The industrial products company reported $0.79 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.79. Xylem had a net margin of 10.90% and a return on equity of 19.23%. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period in the prior year, the firm posted $0.73 earnings per share. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Xylem Inc will post 3.18 EPS for the current fiscal year.
In other Xylem news, insider Kenneth Napolitano sold 5,000 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $80.45, for a total transaction of $402,250.00. Following the sale, the insider now directly owns 46,228 shares of the company’s stock, valued at $3,719,042.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Tomas Brannemo sold 6,683 shares of the company’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $81.90, for a total transaction of $547,337.70. Following the sale, the insider now directly owns 20,161 shares in the company, valued at $1,651,185.90. The disclosure for this sale can be found here. Insiders have sold 46,818 shares of company stock worth $3,747,594 over the last ninety days. Insiders own 0.85% of the company’s stock.
XYL has been the subject of several research analyst reports. Stifel Nicolaus reduced their price target on shares of Xylem from $93.00 to $89.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Zacks Investment Research upgraded shares of Xylem from a “sell” rating to a “hold” rating in a report on Saturday, April 13th. Janney Montgomery Scott upgraded shares of Xylem from a “neutral” rating to a “buy” rating and set a $86.00 target price for the company in a report on Friday, May 3rd. ValuEngine cut shares of Xylem from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Cowen cut shares of Xylem from an “outperform” rating to a “market perform” rating and reduced their target price for the stock from $75.00 to $72.00 in a report on Tuesday, May 14th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $79.69.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Read More: Return on Investment (ROI)
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.